Anacor Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANACOR PHARMS INC, and what generic alternatives to ANACOR PHARMS INC drugs are available?
ANACOR PHARMS INC has two approved drugs.
There are four US patents protecting ANACOR PHARMS INC drugs.
There are one hundred and twenty-five patent family members on ANACOR PHARMS INC drugs in twenty-eight countries and seventeen supplementary protection certificates in fifteen countries.
Summary for Anacor Pharms Inc
International Patents: | 125 |
US Patents: | 4 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Drugs and US Patents for Anacor Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anacor Pharms Inc | EUCRISA | crisaborole | OINTMENT;TOPICAL | 207695-001 | Dec 14, 2016 | RX | Yes | Yes | 9,682,092*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Anacor Pharms Inc | EUCRISA | crisaborole | OINTMENT;TOPICAL | 207695-001 | Dec 14, 2016 | RX | Yes | Yes | 8,501,712*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Anacor Pharms Inc | EUCRISA | crisaborole | OINTMENT;TOPICAL | 207695-001 | Dec 14, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ANACOR PHARMS INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Topical Solution | 5% | ➤ Subscribe | 2018-07-09 |
International Patents for Anacor Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 6266708 | ⤷ Try a Trial |
Hungary | E026021 | ⤷ Try a Trial |
Poland | 1988779 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Anacor Pharms Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2343304 | SPC/GB20/025 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: CRISABOROLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/19/1421 20200401; UK PLGB 00057-1691 20200401 |
2343304 | C202030031 | Spain | ⤷ Try a Trial | PRODUCT NAME: CRISABOROL, OPCIONALMENTE EN FORMA DE UNA SAL FARMACEUTICAMENTE ACEPTABLE; NATIONAL AUTHORISATION NUMBER: EU/1/19/1421; DATE OF AUTHORISATION: 20200327; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/19/1421; DATE OF FIRST AUTHORISATION IN EEA: 20200327 |
2343304 | 20C1024 | France | ⤷ Try a Trial | PRODUCT NAME: CRISABOROLE, OPTIONNELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE; REGISTRATION NO/DATE: EU/1/19/1421 20200401 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.